I N T R O D U C T I O N
The Dietary Approaches to Stop Hypertension (DASH)-style diet, which provides high amounts of whole grains, fruit, vegetables and legumes and nuts; moderate amounts of low-fat dairy and low amounts of red or processed meats, sodium and sweetened beverages, has been widely advocated by the American Heart Association (AHA) for the prevention and treatment of patients with high blood pressure [1] . Although the DASHstyle diet markedly decreases both systolic and diastolic blood pressure (DBP) among patients with hypertension [2] , it has recently received increased attention as a healthy dietary pattern that should be prescribed for prevention and treatment of some other non-communicable diseases (NCDs), including both dyslipidemia and hyperglycemia [3] [4] [5] .
Impaired glucose, lipid profile abnormalities and high blood pressure are known independent risk factors for kidney dysfunction [6] . Among adults with type 2 diabetes, the prevalence of chronic kidney disease (CKD) was 40% [7] and patients with hypertension, pre-hypertension and dyslipidemia have an almost 3-, 2-and 6-fold increased risk of CKD, respectively [8, 9] . Guidelines that provide definitions of CKD recommend an estimated glomerular filtration rate (eGFR) as the best overall measure of kidney function, and CKD is defined as a persistently low GFR of <60 mL/min/1.73 m 2 [10] . While medical treatment is the basis of high blood pressure, lipid profile abnormalities and any form of glucose intolerance, therapy and management of related risk factors and dietary behaviour is also a vital segment of the medical therapy prescribed for these patients. It would be difficult to conduct a long-term randomized clinical trial with CKD as an endpoint, especially among a large population; however, data from observational studies conducted on individuals following a diet similar to the DASH-style diet would be helpful in elucidating the long-term effectiveness of the DASH-style diet.
A few studies have examined the association between the DASH-style diet and kidney function in healthy populations [11] [12] [13] ; however, no study has prospectively examined the association of the DASH-style diet with the incidence of CKD among high-risk populations. Therefore, in this prospective study, we assessed the association between adherence to the low-sodium DASH-style diet and the incidence of CKD after 3 years of follow-up among a high-risk sample of the Tehran Lipid and Glucose Study (TLGS), who had dysglycemia, dyslipidemia and high blood pressure.
M A T E R I A L S A N D M E T H O D S

Study population
This longitudinal study was conducted within the framework of the TLGS, an ongoing community-based prospective investigation aimed at preventing NCDs by developing interventional programmes promoting healthy lifestyles and reducing NCD risk factors. This study was conducted on a sample of residents under the coverage of three medical health centres in District 13 of Tehran, the capital city of Iran. Briefly, using multistage cluster random sampling methods, 15 005 people !3 years of age were selected. The first phase of the TLGS was a cross-sectional study conducted from 1999 to 2001, and Phases II , III (2005-7) , IV (2008-11) and V (2012-15) were prospective follow-up surveys [14] .
For the current study, during the fourth phase of the TLGS (2009-11), of 12 823 participants who had complete data on their medical histories and had undergone physical examinations, 7956 subjects were randomly selected for dietary assessment. Among participants, 6638 men and women !30 years of age were selected; pregnant and lactating women (n ¼ 114), those with missing information on covariates (n ¼ 142), those with a history of myocardial infarction, stroke or cancer (n ¼ 47) and subjects who reported daily energy intakes outside the range of 800-4200 kcal/d (n ¼ 113) were excluded. Some individuals fell into more than one exclusion category. For subgroup analysis, we selected subjects who had dysglycemia (n ¼ 1357), dyslipidemia (n ¼ 3216) or high blood pressure (n ¼ 2472) at baseline . To evaluate the incidence, we also excluded subjects who had CKD (eGFR <60 mL/1.73 m 2 ) at baseline for each subgroup separately (dysglycemia, 247; dyslipidemia, 465; high blood pressure, 365). Eventually, 1100, 2715 and 2089 participants with dysglycemia, dyslipidemia and high blood pressure, respectively, followed during the fifth examination phase remained for the final analysis (Figure 1) . The median follow-up time was 3.12 [25th-75th interquartile range (IQR) 2.86-3.57] in participants with dysglycemia, 3.12 (2.85-3.50) in participants with dyslipidemia, and 3.11 (2.84-3.48) in participants with high blood pressure. The response rate was 80%.
The ethics committee of the Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences approved the study protocol and all experiments were performed in accordance with relevant guidelines and regulations. Written informed consent was obtained from all participants.
Measurements
Dietary measurements. Dietary intake was assessed by expert interviewers using a food frequency questionnaire (FFQ), the reliability and validity of which has been previously reported [15] . Trained dietitians during face-to-face interviews asked participants to designate their consumption frequency for each food item consumed during the previous year on a daily, weekly or monthly basis. Portion sizes of consumed foods that were reported in household measures were then converted to grams. As the Iranian Food Composition Table (FCT) is incomplete, the US Department of Agriculture (USDA) FCT was used; for national foods not listed in the USDA FCT, the Iranian FCT was the alternative. Overall, these data indicate that the FFQ provides reasonably valid measures of the average long-term dietary intake [15] .
Since the original DASH diet is not low in sodium, we used a low-sodium DASH-style diet score, which was constructed based on foods and nutrients focusing on eight components [16] . All components were computed per 1000 kcal and then divided into quintiles. For fruits, vegetables, whole grains, low-fat dairy and nuts and legumes, those in the lowest quintile were given a score of 1 and those in the top quintile received a score of 5. Other quintiles for these components were given corresponding scores. For sodium, red and processed meats and sweetened beverages, the lowest quintile was given a score of 5 and the highest quintile was given a score of 1. Those in quintiles 4, 3 and 2 for these components were given scores of 2, 3 and 4, respectively. We summed the component scores to obtain an overall low-sodium DASH-style diet score ranging from 8 to 40.
Measurement of covariates. Information on physical activity was collected using the Modifiable Activity Questionnaire (MAQ) to calculate metabolic equivalent task (MET) minutes per week. High reliability (98%) and moderate validity (47%) were documented for the Persian translation of MAQ [17] .
Weight was recorded in light clothing to the nearest 0.1 kg on a digital weighing scale (Seca 707; Seca Corporation, Hanover, MD, USA; range 0.1-150 kg) and height was measured without shoes to the nearest 0.1 cm. Arterial blood pressure was measured manually, using a mercury sphygmomanometer with a suitable cuff size for each participant after a 15-min rest in the supine position. Systolic blood pressure (SBP) was determined by the onset of the tapping Korotkoff sound while DBP was determined as the disappearance of the Korotkoff sound. Blood pressure was measured twice and the average was considered as the participant's blood pressure.
Blood samples were taken from all participants at the TLGS research laboratory after an overnight fast of 12-14 h. Fasting plasma glucose (FPG) and 2-h plasma glucose (2-hPG; equivalent to 75 g anhydrous glucose; Cerestar EP, Spain) were assayed by an enzymatic colorimetric method using glucose oxidase with both inter-and intra-assay coefficients of variation (CVs) being <2%. Serum triglycerides (TGs) were assayed using an enzymatic colorimetric method with glycerol phosphate oxidase. Inter-and intra-assay CVs for TGs were 0.6 and 1.6%, respectively. Serum high-density lipoprotein cholesterol (HDL-C) was measured after precipitation of the apolipoprotein B-containing lipoproteins with phosphotungstic acid. Enzymatic colorimetric tests were used to assay total cholesterol (TC) with cholesterol esterase and cholesterol oxidase. Interand intra-assay CV for both TC and HDL-C were 0.5% and 2%, respectively. Low-density lipoprotein cholesterol (LDL-C) was calculated from the serum TC, TG and HDL-C concentrations expressed (in mg/dL) using the Friedewald formula [18] . Serum creatinine was measured according to the standard colorimetric kinetic Jaffe reaction method. Both intra-assay and interassay CVs were <3.1%. All blood analyses were done at the TGLS laboratory. The analysis of samples was performed using the Selectra 2 auto-analyzer (Vital Scientific, Spankeren, The Netherlands) and all analyses were performed using commercial kits (Pars Azmoon, Tehran, Iran).
Definitions. Dyslipidemia was defined as having any of the following abnormalities in the lipid profile: TC !200 mg/dL or TGs !150 mg/dL or HDL <40 mg/dL or current therapy for a definite diagnosis of dyslipidemia [19] . High blood pressure was defined as SBP ! 120 mmHg or DBP ! 80 mmHg or taking antihypertensive medication [20] . We defined dysglycemia as any abnormality in glucose metabolism indicative of diabetes or impaired fasting glucose (IFG) or impaired glucose tolerance (IGT). Diabetes was defined as FPG !126 mg/dL or 2-h PG !200 mg/dL or current therapy for a definite diagnosis of diabetes, IFG was defined as FPG between 100 and 126 mg/dL and IGT was defined as a 2-h PG concentration !140 but < 200 mg/dL [21] .
We used the Modification of Diet in Renal Disease (MDRD) equation formula to express eGFR in mL/min/1.73 m 2 of body surface area [22] . The abbreviated MDRD study equation is as follows: DASH-style diet and kidney dysfunction Subjects were classified based on their eGFR levels by the National Kidney Foundation guidelines [23] : eGFR !60 mL/min/ 1.73 m 2 as not having CKD and eGFR <60 mL/min/1.73 m 2 as having CKD, which corresponds to Stages 3-5 of CKD based on the Kidney Disease Outcomes and Quality Initiative guidelines.
Statistical analysis
The study design was prospective; information on diet was collected at baseline (2009-11) of the current study and serum creatinine was measured at baseline and after 3 years of followup. The low-sodium DASH-style diet score was categorized into quartile cut-off points. Continuous variables were reported as the age-adjusted mean (SE) and categorical variables as percentages. We calculated age-adjusted mean values for participants' characteristics using analysis of covariance (ANCOVA). Tests of a trend for continuous and categorical variables across quartiles of the low-sodium DASH-style diet score (as a median value in each quartile) were conducted using linear regression and chi-square test, respectively.
To examine the association of incident CKD in each quartile of the low-sodium DASH-style diet, multivariable logistic regression models were used and odds ratios (ORs) and 95% confidence intervals (CIs) were calculated; the lowest quartile of the low-sodium DASH-style diet score served as the reference group. The first model was crude; Model 2 was adjusted for age (continuous), sex (male, female), smoking (never, current smoker), total energy intake (continuous), body mass index (BMI; continuous), angiotensin-converting enzyme inhibitor (ACEi; yes, no) and physical activity (low, moderate and high) for all subgroups. In Model 3, subgroups of subjects were mutually adjusted for each other as follows: for high blood pressure, subjects were adjusted for dysglycemia and dyslipidemia, for dysglycemia they were adjusted for high blood pressure and dyslipidemia and for dyslipidemia they were adjusted for dysglycemia and high blood pressure. To calculate the trend of ORs across increasing categories of the low-sodium DASH-style diet, we considered quartile categories as continuous variables.
All data were analyzed using the Statistical Package for the Social Sciences (SPSS), version 15.0 (SPSS, Chicago, IL, USA). P-values <0.05 were considered statistically significant.
R E S U L T S
In subjects with dysglycemia, dyslipidemia and high blood pressure, 16.3, 15.1 and 15.7% incident cases of CKD occurred, respectively. Age-adjusted characteristics for subjects with dyslipidemia, dysglycemia and high blood pressure by quartiles of the low-sodium DASH-style diet score are illustrated in Tables 1-3 . Participants in the highest quartile of the DASH-style diet had less physical activity, were more likely to be males and current smokers and had higher serum creatinine than participants in the lowest quartile at baseline; they were also less likely to have diabetes mellitus at both baseline and the end of follow-up. In addition, creatinine had a descending trend across the quartiles of DASH-style diet at the end of follow-up. Participants with dyslipidemia by increasing low-sodium DASH-style diet scores had a lower DBP and dysglycemia and used antihypertensive drugs and ACEs less frequently at baseline. Subjects with dyslipidemia and high blood pressure in the highest quartile of DASH-style diet score had higher levels of HDL-C and lower levels of TGs at baseline and a higher level of HDL-C at the end of follow-up than their counterparts in the lowest quartile. In all three subgroups, participants in the highest quartile of the lowsodium DASH-style diet score had higher intakes of percentage of energy from protein and carbohydrates. In addition, by increasing adherence to the low-sodium DASH-style diet, intakes of plant protein, dietary fibre, potassium, magnesium and calcium increased, while intakes of animal protein and sodium decreased.
Higher low-sodium DASH-style diet scores were associated with a reduced risk of incident CKD in both the crude and multivariable regression models (Table 4) . After adjusting for age, sex, BMI, total energy intake, ACEs, physical activity and smoking, the OR for subjects with dysglycemia in the highest compared to the lowest quartile of low-sodium DASH-style diet score was 0.58 (95% CI 0.36-0.92; P for trend ¼ 0.019), for subjects with dyslipidemia the OR was 0.64 (95% CI 0.48-0.87; P for trend <0.001) and for subjects with high blood pressure the OR was 0.62 (95% CI 0.44-0.87; P for trend ¼ 0.002). After mutual adjustment, the OR for subjects with hyperglycemia in the highest compared with the lowest quartile of low-sodium DASH-style diet score was 0.59 (95% CI 0.37-0.95; P for trend ¼ 0.025), for subjects with dyslipidemia it was 0.66 (95% CI 0.49-0.90; P for trend ¼ 0.002) and for subjects with high blood pressure it was 0.64 (95% CI 0.45-0.90; P for trend ¼ 0.004).
D I S C U S S I O N
In this longitudinal study we found an $40% decreased risk of incident CKD over 3 years with greater compliance to the lowsodium DASH-style diet among subjects with dysglycemia, dyslipidemia and high blood pressure, a favourable association that persisted even after adjustment for potential confounders and mutual adjustment of dysglycemia, dyslipidemia and high blood pressure.
To the best of our knowledge, there are no studies that have evaluated the relation of a DASH-style diet and CKD outcomes in patients with dysglycemia, dyslipidemia and high blood pressure, patients who have been reported to be at higher risk of developing CKD [24] ; however, several studies have investigated the association of a DASH-style diet in general populations [11, 13, 25] . We previously reported higher adherence to the DASHstyle diet may decrease the risk of incident CKD in the general population. Lin et al. [13] reported that women with higher adherence to the DASH-style diet had a 45% decreased the risk of eGFR decline over 11 years of follow-up, after adjusting for age, hypertension, BMI, physical activity, energy intake, smoking, diabetes, cardiovascular disease and ACEi/ARB medication use. The association was constant in the model that was adjusted for analgesic medications use, high-cholesterol and lipidlowering medications and duration of diabetes [13] . In addition, Chang et al. [25] found that low DASH-style diet scores were positively associated with incident microalbuminuria over a 15-year period, independent of age, sex, family history of kidney disease, education, hypertension and diabetes. Furthermore, lower adherence to the DASH-style diet was associated with increased prevalent CKD among a poor urban population in a crosssectional study [11] .
In the current study we observed that greater concordance with the low-sodium DASH-style diet decreased the risk of CKD among subjects with dysglycemia. Results of a study of 635 diabetic patients from Taiwan demonstrated that by increasing adherence to the 'vegetable and fish' dietary pattern, serum creatinine decreased and eGFR increased [26] ; the 'vegetable and fish' dietary pattern emphasizes foods and nutrients similar to those emphasized in the DASH-style diet, including fruits, vegetables, nuts and legumes and whole grains, which have been shown to reduce the risk of CKD [26] . In another study conducted on diabetics, patients in the highest tertile of the modified Alternate Healthy Eating Index (mAHEI) score had a 20% decreased incidence or progression of CKD compared with those in the lowest tertile [27] ; the mAHEI included high intakes of vegetables, fruit, nuts, multivitamins and whole grains and low intakes of red and processed meats, trans fats and alcohol, close to the definition of the DASH-style diet in the current study. In addition, Dunkler et al. [28] have shown that modifying selected dietary factors including alcohol, vegetables, fruits, proteins, carbohydrates, fried foods, urinary sodium and potassium to assumed optimal levels among patients with diabetes could reduce CKD by 20%. Generally, a healthy diet has been shown to support the management of diabetes. Several components of the DASH-style DASH-style diet and kidney dysfunction diet might help to control blood glucose, blood pressure and lipids, therefore it can reduce the incidence and progression of CKD. Primary components of the DASH diet are whole grains, fruits, vegetables and low-fat dairy products, which are low on the glycemic index and promote glycemic control, thereby preventing and improving microvascular complications [29] . Another potential dietary factor that affects renal function in patients with diabetes is protein intake. Low carbohydrate diets, compared with high carbohydrate ones, without considering the source of protein intake had no further potential effects on kidney function among type 2 diabetic patients [30] . Results from our previous study of non-diabetic participants also show that different origins of dietary protein may impact kidney function differently; higher intakes of animal protein and elevated animal:plant protein ratios had undesirable effects on the prevalence of CKD [31] . Findings from randomized trials confirm that excretion of urinary albumin and renal vasodilatation was higher among groups with diets high in animal protein compared with those with vegetable protein [32] . In addition, lower intakes of red and processed meat among individuals who developed CKD-related risk factors may have an important role in protecting kidney function; substitution of red with white meat in reduced urinary albumin excretion rates and improved microalbuminuria in type 2 diabetes [33] . Based on results of our investigation as well as those of others [32] [33] [34] , the source of protein intake is more important than the number of protein intakes. Indeed, low red and processed meat intake and high vegetable intake appear to be better food choices and may correlate with less risk of nephropathy in diabetics. Higher adherence to the low-sodium DASH-style diet reduced by 36% the risk of incident CKD among subjects with high blood pressure. Among studies evaluating the association between dietary intake and kidney function in hypertensive subjects, the majority focused on salt in the diet [35, 36] . Urinary albumin levels were significantly higher in patients with higher salt intake than those with lower intake [36] ; 24-h urinary albumin excretion was lower among subjects in the intensive low-salt diet group compared with those in the conventional education group [35] .
Findings from a secondary analysis of the DASH study showed that among individuals with pre-hypertension or hypertension, a diet high in fruits and vegetables decreased urinary albumin excretion in those with excretion levels >7 mg/24 h [37] and another interventional trial showed dietary modifications, including reduced salt intake and increasing vegetables and fruits in the diet among patients with hypertension, reduced the urinary albumin:creatinine ratio (UACR) and maintained eGFR [38] . In addition, uric acid, which has been known as a potential contributory risk factor in the development and progression CKD [39] , may decrease among prehypertensive or hypertensive patients by modifying the diet towards greater compliance with the DASHstyle diet [40] . Furthermore, decreasing blood pressure among patients with hypertension by greater adherence to the DASHstyle diet is another potential mechanism [41] . It seems that modification of dietary intake among patients with high blood pressure might be protective against developing kidney dysfunction and reduce the progression of CKD.
Most patients who have dysglycemia, dyslipidemia and high blood pressure need combination therapies to successfully avoid the related adverse effects of these diseases, strategies that Table 3 . Characteristics and dietary intakes of high blood pressure subjects according to quartiles of the low-sodium DASH-style diet a DASH score quartiles DASH-style diet and kidney dysfunction may include both lifestyle interventions and pharmacologic medications. Dysglycemia, dyslipidemia and high blood pressure are well-known risk factors for the onset of CKD [6] . In the current study, the incidence of CKD among participants in each subgroup did not differ significantly, being 16.3, 15.1 and 15.7 for patients with dysglycemia, dyslipidemia and high blood pressure, respectively. Consistent with our study, a study conducted in a European diabetic population >55 years of age showed that after 5.5 years of follow-up the incidence of progression to proteinuria was 13.7%, with a decline in GFR of 9.3% (>5% per year) [27] . Hsu et al. [26] , in a cross-sectional study among 635 diabetic patients !30 years of age, showed that the prevalence of CKD was 10.6%. However, the incidence of CKD in our population, which was lower than that of the Dunkler et al. [27] study, might be justified by our younger population, shorter follow-up time and considering prediabetic versus diabetic patients. Furthermore, Kanno et al. [42] showed that the incidence of CKD among participants with prehypertension was 12.1% and Hanratty et al. [43] observed that among 43 305 subjects with hypertension, 12.1% developed incident CKD after 3.6 years of follow-up. Both studies showed that in subjects with prehypertension and hypertension, the incidence of CKD was close to that of the current study. Dietary interventions are more cost effective than effects that have been shown to be achieved with medical therapy alone, although it is difficult to conduct a long-term randomized clinical trial among populations at high risk for CKD, especially for secondary prevention. Data from observational studies show that following a diet similar to the DASH-style diet may be helpful in elucidating the long-term effectiveness of the DASH diet. In addition, dietary guidelines for high-risk patients recommend intakes of individual nutrients or food items [44] . Indeed, an applicable and feasible dietary score in a specific population to predict risk factors in a prospective framework may help policymakers design and implement suitable interventional strategies and programmes. Therefore, clinicians could recommend the low-sodium DASH-style diet as one preventive segment of therapies to reduce the future burden of these diseases.
Several limitations of this investigation need to be mentioned. First, our definition of CKD, as in most epidemiologic studies, is based on a limited number of isolated creatinine measurements that were not repeated within 3 months to confirm a chronic reduction in GFR. Second, data on the proteinuria of the participants was not documented and we were unable to consider it in the definition of CKD. Third, despite controlling for various confounders in our analysis, residual confounding due to unknown or unmeasured confounders cannot be excluded. Finally, using an FFQ cannot estimate the 'actual' intake of participants, but can be used to rank individuals based on their long-term adherence to the low-sodium DASH-style diet.
This study has several strengths. Unlike previous studies, it provides data based on habitual dietary intakes in a populationbased sample of participants, increasing the generalizability of its results. Furthermore, the FFQ was designed to estimate typical food and beverage consumption over the previous year, ignoring infrequently consumed items and seasonal variations, which is not possible when using a 24-h dietary recall.
In summary, greater adherence to the low-sodium DASHstyle diet might reduce the risk of incident CKD in patients with dysglycemia, dyslipidemia and high blood pressure. Therefore, a low-sodium DASH-style diet could be recommended as one preventive segment of therapy to reduce the future burden of these diseases. In all subgroups, by increasing adherence to the low-sodium DASH-style diet, intakes of plant protein, fibre, magnesium, potassium and calcium increased and intakes of animal protein, fat and sodium declined.
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A B S T R A C T
Background. It has been suggested that the prognosis of immunoglobulin (IgA) nephropathy (IgAN) is adversely affected if there is codeposition of IgG in the glomeruli or if immune deposits are present in the glomerular capillary walls. We sought to understand how these variables affect clinical outcome. Methods. A total of 80 IgAN biopsies were retrospectively divided into groups: (i) IgA without IgG deposition versus IgA þ IgG and (ii) immune deposits restricted to the mesangium versus mesangium and peripheral capillary walls (PCWs). The association of these groups with the composite primary outcome of renal replacement therapy, renal transplant, death or doubling of serum creatinine (SCr) concentration was determined. The change in estimated glomerular filtration rate (eGFR) was also assessed. Covariates examined were age, sex, race, SCr and proteinuria level at biopsy and at follow-up, duration of follow-up, treatment, Oxford score and presence of crescents. Results. IgG codeposition showed a trend toward endocapillary hypercellularity (P ¼ 0.082); there were no other baseline differences between the IgA (n ¼ 55) and IgA þ IgG (n ¼ 25) groups. At a median follow-up time of 29 months, the combined primary outcome was reached in 24 patients, 16 with IgA and 8 with IgA þ IgG (P ¼ 0.82). Patients with immune deposits in the PCWs (n ¼ 21) presented with higher baseline proteinuria than those with deposits limited to the mesangium (n ¼ 59; P ¼ 0.025), were more likely to have crescents/segmental glomerular necrosis on biopsy (P ¼ 0.047) and were more likely to reach the combined primary outcome (P ¼ 0.026). Biopsies with crescents/segmental glomerular necrosis were associated with endocapillary hypercellularity (P < 0.001). Conclusions. In this multicenter IgAN cohort, IgG codeposition and the location of glomerular immune deposits in
